Please try another search
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Charles C. Francisco | 85 | 1991 | Director |
Michael P. O'Flaherty | 85 | - | Director |
Mark G. Lewis | 68 | 2010 | Chairman of the Board, CEO & President |
David A. Newcomer | 62 | 2022 | Non-Independent Director |
Charles F. Gauvin | 67 | 1992 | Director |
David B. Landon | 60 | 2017 | Director |
Vivek R. Shinde Patil | - | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review